The Dow Chemical Company and Subsidiaries
f PART III p
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Information relating to Directors, certain executive officers and certain corporate governance matters (including identification
of Audit Committee members and financial expert(s)) is contained in the definitive Proxy Statement for the 2017 Annual
Meeting of Stockholders of The Dow Chemical Company and is incorporated herein by reference. See also the information
regarding executive officers of the registrant set forth in Part I, Item 1. Business under the caption “Executive Officers of the
Registrant” in reliance on General Instruction G to Form 10-K.
On July 10, 2003, the Board of Directors of the Company adopted a code of ethics that applies to its principal executive officer,
principal financial officer and principal accounting officer, and is incorporated herein by reference to Exhibit 14 to the
Company’s Annual Report on Form 10-K for the year ended December 31, 2003.
ITEM 11. EXECUTIVE COMPENSATION
Information relating to executive compensation and the Company’s equity compensation plans is contained in the definitive
Proxy Statement for the 2017 Annual Meeting of Stockholders of The Dow Chemical Company and is incorporated herein by
reference.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED
STOCKHOLDER MATTERS
Information with respect to beneficial ownership of Dow common stock by each Director and all Directors and executive
officers of the Company as a group is contained in the definitive Proxy Statement for the 2017 Annual Meeting of Stockholders
of The Dow Chemical Company and is incorporated herein by reference.
Information relating to any person who beneficially owns in excess of 5 percent of the total outstanding shares of Dow
common stock is contained in the definitive Proxy Statement for the 2017 Annual Meeting of Stockholders of The Dow
Chemical Company and is incorporated herein by reference.
Information with respect to compensation plans under which equity securities are authorized for issuance is contained in the
definitive Proxy Statement for the 2017 Annual Meeting of Stockholders of The Dow Chemical Company and is incorporated
herein by reference.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Reportable relationships and related transactions, if any, as well as information relating to director independence are contained
in the definitive Proxy Statement for the 2017 Annual Meeting of Stockholders of The Dow Chemical Company and are
incorporated herein by reference.
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
Information with respect to fees and services related to the Company’s independent auditors, Deloitte & Touche LLP, and the
disclosure of the Audit Committee’s pre-approval policies and procedures are contained in the definitive Proxy Statement for
the 2017 Annual Meeting of Stockholders of The Dow Chemical Company and are incorporated herein by reference.
157